Pharmacokinetics of nilotinib in imatinib‐resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure
Open Access
- 19 January 2012
- journal article
- other
- Published by Wiley in American Journal of Hematology
- Vol. 87 (4) , 451
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid LeukemiaNew England Journal of Medicine, 2010
- High‐performance liquid chromatography with solid‐phase extraction for the quantitative determination of nilotinib in human plasmaBiomedical Chromatography, 2009
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALLInternational Journal of Hematology, 2009
- Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysisAmerican Journal of Hematology, 2006
- Pharmacokinetics of imatinib mesylate in end stage renal disease. A case studyCancer Chemotherapy and Pharmacology, 2005